Venture Life Group plc (AIM:VLG)
London · Delayed Price · Currency is GBP · Price in GBX | Market Cap | 82.75M +20.8% |
| Revenue (ttm) | 35.27M +32.6% |
| Net Income | 2.41M |
| EPS | 0.02 |
| Shares Out | 119.92M |
| PE Ratio | 34.35 |
| Forward PE | 9.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 567,062 |
| Open | 68.25 |
| Previous Close | 69.00 |
| Day's Range | 68.00 - 70.00 |
| 52-Week Range | 52.00 - 72.00 |
| Beta | 0.17 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 1, 2026 |
About Venture Life Group
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers women’s healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. It also provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; and Glucogel for the treatment of hypoglycaemia. In addition, the company offers ENT care products... [Read more]
Financial Performance
In fiscal year 2026, Venture Life Group's revenue was 35.27 million, an increase of 0.30% compared to the previous year's 35.17 million. Earnings were 2.41 million, a decrease of -60.67%.
Financial StatementsNews
Venture Life Group Transcript: Transition period
Transformed into a focused consumer healthcare business, achieving 20%+ growth in power brands and strong gross margins. Expanded into the U.S. with the FemiClear acquisition, maintaining a robust balance sheet and targeting GBP 55 million revenue for the next year.
Venture Life Group Annual report: Transition period
Venture Life Group has published an annual report on October 1, 2026.
Venture Life Group Annual report: Transition period
Venture Life Group has published an annual report on October 1, 2026.
Venture Life Group Slides: Transition period
Venture Life Group has posted slides in relation to its latest quarterly earnings report, which was published on October 1, 2026.
Venture Life Group Earnings release: Trading update
Venture Life Group released its earnings on June 30, 2026, summarizing the period's financial results.
Venture Life Group Earnings Call Transcript: H2 2025
Major divestments and a shift to a brand-focused model drove 11% organic and 32% reported revenue growth, with strong cash generation and double-digit growth continuing into 2026. Power brands excelled, especially in women's and men's health, while digital transformation and innovation underpin future expansion.
Venture Life Group Annual report: H2 2025
Venture Life Group has published its H2 2025 annual report on April 2, 2026.
Venture Life Group Slides: H2 2025
Venture Life Group has posted slides in relation to its H2 2025 quarterly earnings report, which was published on April 2, 2026.
Venture Life Group Earnings release: H2 2025
Venture Life Group released its H2 2025 earnings on January 26, 2026, summarizing the period's financial results.